2017-03-13,Biotech Premarket Movers: Cempra, Blueprint Medicines, Aralez
2017-03-13,Cempra Retains Morgan Stanley To Lead Review Of Strategic Business Options
2017-03-03,Cempra To Present At 29th Annual ROTH Conference
2017-02-28,Biotech Premarket Movers: Cempra, Novavax, Ionis
2017-02-28,Cempra Provides Corporate Update And Reports Fourth Quarter And Full Year 2016 Financial Results
2017-02-27,Biotech Premarket Movers: BioCryst, Sangamo, Cempra
2017-02-24,4 Biotech Stocks on the Move
2017-02-24,Biotech Movers: Cempra Flys High On Phase Three Results
2017-02-24,Cempra's Fusidic Acid Achieves Primary Endpoint In Phase 3 Study Of ABSSSI
2017-02-14,Cempra To Report Fourth Quarter And Full Year 2016 Financial Results
2017-02-09,Acorda, Amgen and Regeneron Lead Premarket Biotech Movers
2017-02-08,CORRECTING And REPLACING -- Cempra To Present At Upcoming Investor Conferences
2017-02-08,Cempra To Present At Upcoming Investor Conferences
2017-01-04,Cempra To Present At J.P. Morgan Healthcare Conference
2017-01-03,INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders Of Cempra, Inc. Of A Class Action Lawsuit And A Lead Plaintiff Deadline Of January 3, 2017
2016-12-30,GPM Reminds Investors Of The January 3 Deadline In The Class Action Lawsuit Against Cempra, Inc.
2016-12-29,Wall Street Falls Again as Financial Stocks Lead the Decline
2016-12-29,Wall Street Slumps As Financial Stocks Lead the Decline
2016-12-29,Midday Report: Volatile Stocks Turn Negative; Cempra Plummets, Sears Soars
2016-12-29,Stocks Volatile After Trade Deficit Data; Oil Inventories Rise
2016-12-29,Cempra Receives Complete Response Letter From FDA For Solithromycin NDAs
2016-12-27,CEMP SHAREHOLDER ALERT: The Law Offices Of Vincent Wong Reminds Shareholders Of Commencement Of A Class Action Involving Cempra, Inc. And A Lead Plaintiff Deadline Of January 3, 2017
2016-12-23,CEMP INVESTOR ALERT: The Law Offices Of Vincent Wong Reminds Shareholders Of Commencement Of A Class Action Involving Cempra, Inc. And A Lead Plaintiff Deadline Of January 3, 2017
2016-12-20,Interesting CEMP Put And Call Options For February 2017
2016-12-16,CEMP SHAREHOLDER ALERT: The Law Offices Of Vincent Wong Reminds Shareholders Of A Class Action Involving Cempra, Inc. And A Lead Plaintiff Deadline Of January 3, 2017
2016-12-15,CEMP LOSS NOTICE: Rosen Law Firm Reminds Cempra, Inc. Investors Of Important Deadline In Class Action - CEMP
2016-12-14,CEMPRA INC. INVESTOR REMINDER: Hagens Berman Reminds Cempra Investors Of Lead Plaintiff Deadline
2016-12-12,Cempra Appoints Dr. David Zaccardelli As Acting Chief Executive Officer, Promotes Chief Commercial Officer David Moore To President
2016-12-07,DEADLINE ALERT: Brower Piven Alerts Shareholders Of Approaching Deadline In Class Action Lawsuit And Encourages Those With Losses In Excess Of $100,000 From Investment In Cempra, Inc. To Contact The Firm
2016-12-05,Toyama Chemical (a Subsidiary Of FUJIFILM Holdings Corporation) Begins Phase 3 Studies In Japan With Cempra's Solithromycin
2016-12-01,Lifshitz & Miller Law Firm Announces Investigation Of Adeptus Health Inc., Avid Technology, Inc., Cempra, Inc., Clovis Oncology, Inc., Impax Laboratories, Inc., Ligand Pharmaceuticals Incorporated, Pattern Energy Group Inc. And Kandi Technologies Group, Inc.
2016-11-30,Rosen Law Firm Reminds Cempra, Inc. Investors Of Important Deadline In Class Action - CEMP
2016-11-28,SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Cempra, Inc. To Contact The Firm Before Lead Plaintiff Deadline
2016-11-28,Short Interest Decreases By 21.6% For CEMP
2016-11-23,'Mad Money' Lightning Round: Jim Cramer Sees Steel Companies Shining
2016-11-22,Robbins Geller Rudman & Dowd LLP Files Class Action Suit Against Cempra, Inc.
2016-11-22,Jim Cramer's 'Mad Money' Recap: Expect More Earnings Surprises
2016-11-22,First Week of CEMP July 2017 Options Trading
2016-11-16,CEMPRA (CEMP) SHAREHOLDER ALERT: Johnson & Weaver, LLP Announces Filing Of Class Action Complaint Against Cempra, Inc.; Encourages All Investors To Contact The Firm For Information
2016-11-14,SHAREHOLDER ALERT: Securities Class Action Lawsuit Against Cempra Announced By Holzer & Holzer; Firm Investigating Expanded Class Period
2016-11-11,SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses On Their Investment In Cempra, Inc. Of Class Action Lawsuit And Upcoming Deadline - CEMP
2016-11-11,EQUITY ALERT: Rosen Law Firm Announces Filing Of Securities Class Action Lawsuit Against Cempra, Inc.
2016-11-09,Cempra To Present At Two Upcoming Investor Conferences
2016-11-08,IMPORTANT INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit Against Cempra, Inc. And Encourages Investors With Losses In Excess Of $250,000 To Contact The Firm
2016-11-08,SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors Of Class Action Against Cempra Inc. (CEMP) And Lead Plaintiff Deadline - January 3, 2017
2016-11-08,IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit Against Cempra, Inc. And Encourages Investors With Losses To Contact The Firm
2016-11-07,IMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit Against Cempra, Inc. And Encourages Investors With Losses In Excess Of $250,000 To Contact The Firm
2016-11-07,EQUITY ALERT: Rosen Law Firm Announces Filing Of Securities Class Action Lawsuit Against Cempra, Inc. - CEMP
2016-11-07,Cempra Antibiotic Approval Still in Doubt Even With Positive FDA Panel Vote
2016-11-04,FDA Advisory Committee Votes That Efficacy Results Of Cempra's Solithromycin Outweigh Risks For Community-Acquired Bacterial Pneumonia
2016-11-04,Cempra Stock Trading Halted Today; FDA Advisory Committee To Discuss Solithromycin
2016-11-03,Cempra (CEMP) Stock Downgraded at JPMorgan on FDA Pneumonia Drug Review
2016-11-03,SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf Of Investors Of Cempra, Inc. - CEMP
2016-11-03,IMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces An Investigation Of Cempra, Inc. And Advises Investors With Losses To Contact The Firm
2016-11-03,SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation Of Cempra Inc. (CEMP)
2016-11-03,'Mad Money' Lightning Round: J.C. Penney Is 'A Lot Better,' Jim Cramer Says
2016-11-02,Jim Cramer's 'Mad Money' Recap: It's Chicago Versus Cleveland -- Stocks, That Is
2016-11-02,INVESTOR ALERT: Goldberg Law PC Announces An Investigation Of Cempra, Inc. And Advises Investors With Losses In Excess Of $200,000 To Contact The Firm
2016-11-02,SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces The Commencement Of An Investigation Involving Possible Securities Fraud Violations By Certain Officers And Directors Of Cempra, Inc.
2016-11-02,IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces An Investigation Of Cempra, Inc. And Encourages Investors With Losses To Contact The Firm
2016-11-02,SHAREHOLDER ALERT: Brower Piven Commences An Investigation Into Cempra Inc. And Encourages Investors To Contact The Firm For Additional Information
2016-11-01,Cempra Receives $10 Million Milestone Payment From Toyama Chemical (a Subsidiary Of FUJIFILM Holdings Corporation) As Solithromycin Progresses To Phase 3 Studies In Japan
2016-10-31,Bullish and Bearish Reversals for the Week
2016-10-27,Cempra Reports Third Quarter 2016 Financial Results And Provides Corporate Update
2016-10-25,Cempra To Report Third Quarter 2016 Financial Results
2016-10-04,Cempra Presents Analysis Showing Rates Of Failure For Existing CABP Antibiotics From Claims Database At Academy Of Managed Care Pharmacy Meeting
2016-09-29,Cempra Announces Anti-NASH Effects Of Solithromycin: Interim Results From Phase 2 Study
2016-09-16,Cempra Is Ready to Run
2016-09-14,These 5 Biotech Stocks Are Ready for a Volatility Break
2016-09-01,Cempra To Present At Three Upcoming Investor Conferences
2016-08-30,Cempra To Present Solithromycin At FDA Antimicrobial Drugs Advisory Committee Meeting On November 4, 2016
2016-08-25,Cempra's Pivotal Phase 3 SOLITAIRE-IV Study Of IV To Oral Solithromycin Published In Clinical Infectious Diseases
2016-08-23,Cempra Announces European Medicines Agency Validates MAA For Solithromycin For Treatment Of CABP
2016-08-11,Cempra Appoints Dr. David Zaccardelli To Board Of Directors
2016-08-08,Perilous Reversal Watch: Cempra (CEMP)
2016-08-01,Cempra Reports Second Quarter 2016 Financial Results And Provides Corporate Update
2016-08-01,Cempra (CEMP) Is Today's Strong On High Volume Stock
2016-08-01,Cempra Appoints John Bluth Executive Vice President, Investor Relations And Corporate Communications
2016-07-25,Cempra To Report Second Quarter 2016 Financial Results
2016-07-14,Antibiotic for Treatment of Superbugs Could Send Cempra Shares Soaring
2016-07-12,Cempra (CEMP) Is Today's Strong On High Volume Stock
2016-07-05,Cempra Announces FDA Acceptance Of Solithera™ New Drug Applications In The Treatment Of Community-Acquired Bacterial Pneumonia
2016-06-28,Cempra Submits Marketing Authorization Application To EMA For Solithromycin In The Treatment Of Community-Acquired Bacterial Pneumonia
2016-06-21,Commit To Purchase Cempra At $15, Earn 36.5% Annualized Using Options
2016-06-16,Cempra To Host Analyst And Investor Day On June 23, 2016
2016-06-13,Strong On High Volume: Cempra (CEMP)
2016-06-10,Cempra Announces Solithromycin Presentations At ASM Microbe 2016 Conference
2016-06-06,Today's Dead Cat Bounce Stock: Cempra (CEMP)
2016-06-03,Cempra (CEMP) Stock: Weak On High Volume Today
2016-06-02,Cempra To Present At The Jefferies 2016 Healthcare Conference
2016-05-25,Cempra Announces Successful Results In The Phase 2 Community Acquired Bacterial Pneumonia (CABP) Trial Conducted By Japanese Partner, Toyama Chemical (a Subsidiary Of FUJIFILM Holdings Corporation)
2016-05-12,Cempra To Present Solithromycin IV Data At ATS 2016
2016-05-10,Cempra (CEMP): Today's Weak On High Volume Stock
2016-05-02,Cempra (CEMP) Strong On High Relative Volume Today
2016-05-01,Cempra Reports First Quarter 2016 Financial Results And Provides Corporate Update
2016-05-01,Cempra Completes NDA Submissions For Solithromycin In The Treatment Of Community-Acquired Bacterial Pneumonia
2016-04-25,Cempra To Report First Quarter 2016 Financial Results
2016-04-11,Facebook, Ford and General Motors: Doug Kass' Views
2016-04-06,Cempra To Present At The Needham And Company 15th Annual Healthcare Conference
2016-04-04,Cempra To Present Data On Solithromycin At ECCMID
2016-03-23,First Week of May 20th Options Trading For Cempra (CEMP)
2016-03-16,Insiders Now Seeing Red With CEMP At New 52-Week Low
2016-03-08,Cempra To Participate In Nature's Webcast On Combating Antibiotic Resistance On March 9
2016-03-07,Cempra Authorized To Receive Funds From BARDA For A Phase 2/3 Clinical Trial Of Solithromycin In Pediatric Patients
2016-03-07,Tesla, Amazon and Netflix: Doug Kass' Views
2016-03-01,CEMP: Insiders vs. Shorts
2016-03-01,Weak On High Volume: Cempra (CEMP)
2016-02-29,Cempra To Present At The Cowen And Company 36th Annual Healthcare Conference
2016-02-25,Interesting CEMP Put And Call Options For October 21st
2016-02-24,Cempra Reports Fourth Quarter And Full Year 2015 Financial Results And Provides Corporate Update
2016-02-19,What Carl Icahn Is Doing; Biotech Breakout: Best of Kass
2016-02-17,Cempra To Report Fourth Quarter And Full Year 2015 Financial Results
2016-02-15,JPMorgan, Deutsche Bank and Gilead Sciences: Doug Kass' Views
2016-02-05,The Lancet Infectious Diseases Publishes Positive Phase 3 Study Results For Cempra's Oral Solithromycin In Community-Acquired Bacterial Pneumonia
2016-02-03,Oversold Conditions For Cempra (CEMP)
2016-02-03,Cempra To Present At The Leerink Partners 5th Annual Global Healthcare Conference
2016-02-01,Cempra And Macrolide Pharmaceuticals Enter Synthetic Manufacturing Process Development Agreement For Solithromycin
2016-02-01,Biotech String: Assessing the January Damage, Gilead's Bottoming P/E, Sarepta Panel Date?
2016-01-29,Short Interest Moves 11.4% Lower For CEMP
2016-01-28,Spreading Zika Virus Is a Cause for Alarm, Says Cempra CEO
2016-01-28,Spreading Zika Virus Is a Cause for Alarm, Says Cempra CEO
2016-01-26,Cempra To Ring NASDAQ Closing Bell To Mark 10th Anniversary
2016-01-22,Interesting CEMP Put And Call Options For March 18th
2016-01-12,Cempra Completes Public Offering Of Common Stock
2016-01-07,Oversold Conditions For Cempra (CEMP)
2016-01-07,Heavy Trading On Cempra (CEMP) Before Market Open
2016-01-06,Cempra Prices Public Offering Of Common Stock
2016-01-06,Cempra To Present At J.P. Morgan Healthcare Conference
2016-01-05,Cempra Announces Proposed Public Offering Of $175 Million Of Common Stock
2016-01-05,Trade-Ideas: Cempra (CEMP) Is Today's "Dead Cat Bounce" Stock
2016-01-05,Cempra Doses Initial Patient In Phase 2 Clinical Trial Of Solithromycin In NASH
2015-12-29,2 Speculative Biotech Stocks for 2016
2015-12-22,Cempra Enters Into A CRADA With The NIAID And Expands The Phase 3 Solithromycin Clinical Trial In Urogenital Gonorrhea To Include Additional Female Patients And Adolescents
2015-12-09,Perilous Reversal Watch: Cempra (CEMP)
2015-12-08,Cempra Doses First Patient In Phase 3 Clinical Trial Of Taksta(TM) In Acute Bacterial Skin And Skin Structure Infections
2015-12-01,CEMP: Insiders vs. Shorts
2015-11-24,First Week of July 2016 Options Trading For Cempra (CEMP)
2015-11-24,Cempra (CEMP) Is Today's Perilous Reversal Stock
2015-11-11,Cempra To Present Anti-NASH Data For Solithromycin At The Liver Meeting(R) 2015
2015-11-10,Cempra To Present At Two Upcoming Investor Conferences
2015-11-02,Cempra (CEMP) Is Today's Dead Cat Bounce Stock
2015-10-30,Cempra’s New Drug Holds Potential, but Risk for Investors
2015-10-26,Cempra (CEMP) In A Perilous Reversal
2015-10-23,Cempra To Present Solithromycin Oral Data At CHEST 2015
2015-10-22,Cempra (CEMP): Today's Weak On High Volume Stock
2015-10-22,Cempra Reports Third Quarter 2015 Financial Results And Provides Corporate Update
2015-10-19,Cempra To Report Third Quarter 2015 Financial Results
2015-10-16,4 Big Stocks on Traders' Radars -- and What You Should Do With Them Now
2015-10-16,Heavy Trading On Cempra (CEMP) Before Market Open
2015-10-16,Cempra Announces Positive Topline Phase 3 Clinical Results For Intravenous Solithromycin In The Treatment Of Community-Acquired Bacterial Pneumonia
2015-10-14,Today's Dead Cat Bounce Stock: Cempra (CEMP)
2015-10-05,Cempra To Present Solithromycin Data At ID Week 2015
2015-09-24,Cempra To Present Solithromycin Data In COPD Patient Subgroup At European Respiratory Society International Congress
2015-09-22,Analysts Say Buy Select Biotech Stocks Ahead Of Clinton Drug Plan
2015-09-18,Strong On High Volume: Cempra (CEMP)
2015-09-18,FDA Grants Qualified Infectious Disease Product Designation To Taksta(TM) Cempra's Fusidic Acid Antibiotic
2015-09-16,CEMP Makes Notable Cross Below Critical Moving Average
2015-09-10,Cempra To Present Data From Antibiotic Drug Development Programs At ICAAC/ICC 2015 Meeting
2015-09-09,Trade-Ideas: Cempra (CEMP) Is Today's Weak On High Relative Volume Stock
2015-09-08,Cempra (CEMP) Flagged As Strong On High Volume
2015-09-03,Cempra To Present At Three Upcoming Investor Conferences
2015-08-20,Cempra (CEMP) In A Perilous Reversal
2015-08-19,FDA Grants Fast Track Designation To Cempra For Solithromycin In The Treatment Of Community Acquired Bacterial Pneumonia
2015-08-07,Today's Weak On High Volume Stock: Cempra (CEMP)
2015-08-04,Cempra To Present At The Wedbush PacGrow 2015 Healthcare Conference
2015-07-31,Cempra (CEMP) Is Today's Dead Cat Bounce Stock
2015-07-29,Cempra Reports Second Quarter 2015 Financial Results And Provides Corporate Update
2015-07-22,Cempra To Report Second Quarter 2015 Financial Results
2015-07-21,First Week Of CEMP September 18th Options Trading
2015-07-21,Stock To Watch: Cempra (CEMP) In Perilous Reversal
2015-07-17,New Lifetime High Reached: Cempra (CEMP)
2015-07-07,Cempra Completes Patient Enrollment Of Solitaire-IV Phase 3 Clinical Trial
2015-07-01,Cempra (CEMP) Is Today's Perilous Reversal Stock
2015-06-30,Cempra (CEMP) Showing Signs Of A Dead Cat Bounce Today
2015-06-24,Stock To Watch: Cempra (CEMP) In Perilous Reversal
2015-05-26,Cempra To Present At The Jefferies 2015 Global Healthcare Conference
2015-05-19,First Week Of January 2016 Options Trading For Cempra (CEMP)
2015-05-19,Cempra Presenting Additional Data From The Phase 3 Oral Solithromycin Study In Community Acquired Bacterial Pneumonia At The American Thoracic Society Conference
2015-05-12,Cempra To Present Solithromycin Data At Two Upcoming Medical Conferences
2015-05-01,Trade-Ideas: Cempra (CEMP) Is Today's Strong On High Relative Volume Stock
2017-03-13,Biotech Premarket Movers: Cempra, Blueprint Medicines, Aralez
2017-03-13,Cempra Retains Morgan Stanley To Lead Review Of Strategic Business Options
2017-03-03,Cempra To Present At 29th Annual ROTH Conference
2017-02-28,Biotech Premarket Movers: Cempra, Novavax, Ionis
2017-02-28,Cempra Provides Corporate Update And Reports Fourth Quarter And Full Year 2016 Financial Results
2017-02-27,Biotech Premarket Movers: BioCryst, Sangamo, Cempra
2017-02-24,4 Biotech Stocks on the Move
2017-02-24,Biotech Movers: Cempra Flys High On Phase Three Results
2017-02-24,Cempra's Fusidic Acid Achieves Primary Endpoint In Phase 3 Study Of ABSSSI
2017-02-14,Cempra To Report Fourth Quarter And Full Year 2016 Financial Results
2017-02-09,Acorda, Amgen and Regeneron Lead Premarket Biotech Movers
2017-02-08,CORRECTING And REPLACING -- Cempra To Present At Upcoming Investor Conferences
2017-02-08,Cempra To Present At Upcoming Investor Conferences
2017-01-04,Cempra To Present At J.P. Morgan Healthcare Conference
2017-01-03,INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders Of Cempra, Inc. Of A Class Action Lawsuit And A Lead Plaintiff Deadline Of January 3, 2017
2016-12-30,GPM Reminds Investors Of The January 3 Deadline In The Class Action Lawsuit Against Cempra, Inc.
2016-12-29,Wall Street Falls Again as Financial Stocks Lead the Decline
2016-12-29,Wall Street Slumps As Financial Stocks Lead the Decline
2016-12-29,Midday Report: Volatile Stocks Turn Negative; Cempra Plummets, Sears Soars
2016-12-29,Stocks Volatile After Trade Deficit Data; Oil Inventories Rise
2016-12-29,Cempra Receives Complete Response Letter From FDA For Solithromycin NDAs
2016-12-27,CEMP SHAREHOLDER ALERT: The Law Offices Of Vincent Wong Reminds Shareholders Of Commencement Of A Class Action Involving Cempra, Inc. And A Lead Plaintiff Deadline Of January 3, 2017
2016-12-23,CEMP INVESTOR ALERT: The Law Offices Of Vincent Wong Reminds Shareholders Of Commencement Of A Class Action Involving Cempra, Inc. And A Lead Plaintiff Deadline Of January 3, 2017
2016-12-20,Interesting CEMP Put And Call Options For February 2017
2016-12-16,CEMP SHAREHOLDER ALERT: The Law Offices Of Vincent Wong Reminds Shareholders Of A Class Action Involving Cempra, Inc. And A Lead Plaintiff Deadline Of January 3, 2017
2016-12-15,CEMP LOSS NOTICE: Rosen Law Firm Reminds Cempra, Inc. Investors Of Important Deadline In Class Action - CEMP
2016-12-14,CEMPRA INC. INVESTOR REMINDER: Hagens Berman Reminds Cempra Investors Of Lead Plaintiff Deadline
2016-12-12,Cempra Appoints Dr. David Zaccardelli As Acting Chief Executive Officer, Promotes Chief Commercial Officer David Moore To President
2016-12-07,DEADLINE ALERT: Brower Piven Alerts Shareholders Of Approaching Deadline In Class Action Lawsuit And Encourages Those With Losses In Excess Of $100,000 From Investment In Cempra, Inc. To Contact The Firm
2016-12-05,Toyama Chemical (a Subsidiary Of FUJIFILM Holdings Corporation) Begins Phase 3 Studies In Japan With Cempra's Solithromycin
2016-12-01,Lifshitz & Miller Law Firm Announces Investigation Of Adeptus Health Inc., Avid Technology, Inc., Cempra, Inc., Clovis Oncology, Inc., Impax Laboratories, Inc., Ligand Pharmaceuticals Incorporated, Pattern Energy Group Inc. And Kandi Technologies Group, Inc.
2016-11-30,Rosen Law Firm Reminds Cempra, Inc. Investors Of Important Deadline In Class Action - CEMP
2016-11-28,SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Cempra, Inc. To Contact The Firm Before Lead Plaintiff Deadline
2016-11-28,Short Interest Decreases By 21.6% For CEMP
2016-11-23,'Mad Money' Lightning Round: Jim Cramer Sees Steel Companies Shining
2016-11-22,Robbins Geller Rudman & Dowd LLP Files Class Action Suit Against Cempra, Inc.
2016-11-22,Jim Cramer's 'Mad Money' Recap: Expect More Earnings Surprises
2016-11-22,First Week of CEMP July 2017 Options Trading
2016-11-16,CEMPRA (CEMP) SHAREHOLDER ALERT: Johnson & Weaver, LLP Announces Filing Of Class Action Complaint Against Cempra, Inc.; Encourages All Investors To Contact The Firm For Information
2016-11-14,SHAREHOLDER ALERT: Securities Class Action Lawsuit Against Cempra Announced By Holzer & Holzer; Firm Investigating Expanded Class Period
2016-11-11,SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses On Their Investment In Cempra, Inc. Of Class Action Lawsuit And Upcoming Deadline - CEMP
2016-11-11,EQUITY ALERT: Rosen Law Firm Announces Filing Of Securities Class Action Lawsuit Against Cempra, Inc.
2016-11-09,Cempra To Present At Two Upcoming Investor Conferences
2016-11-08,IMPORTANT INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit Against Cempra, Inc. And Encourages Investors With Losses In Excess Of $250,000 To Contact The Firm
2016-11-08,SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors Of Class Action Against Cempra Inc. (CEMP) And Lead Plaintiff Deadline - January 3, 2017
2016-11-08,IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit Against Cempra, Inc. And Encourages Investors With Losses To Contact The Firm
2016-11-07,IMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit Against Cempra, Inc. And Encourages Investors With Losses In Excess Of $250,000 To Contact The Firm
2016-11-07,EQUITY ALERT: Rosen Law Firm Announces Filing Of Securities Class Action Lawsuit Against Cempra, Inc. - CEMP
2016-11-07,Cempra Antibiotic Approval Still in Doubt Even With Positive FDA Panel Vote
2016-11-04,FDA Advisory Committee Votes That Efficacy Results Of Cempra's Solithromycin Outweigh Risks For Community-Acquired Bacterial Pneumonia
2016-11-04,Cempra Stock Trading Halted Today; FDA Advisory Committee To Discuss Solithromycin
2016-11-03,Cempra (CEMP) Stock Downgraded at JPMorgan on FDA Pneumonia Drug Review
2016-11-03,SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf Of Investors Of Cempra, Inc. - CEMP
2016-11-03,IMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces An Investigation Of Cempra, Inc. And Advises Investors With Losses To Contact The Firm
2016-11-03,SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation Of Cempra Inc. (CEMP)
2016-11-03,'Mad Money' Lightning Round: J.C. Penney Is 'A Lot Better,' Jim Cramer Says
2016-11-02,Jim Cramer's 'Mad Money' Recap: It's Chicago Versus Cleveland -- Stocks, That Is
2016-11-02,INVESTOR ALERT: Goldberg Law PC Announces An Investigation Of Cempra, Inc. And Advises Investors With Losses In Excess Of $200,000 To Contact The Firm
2016-11-02,SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces The Commencement Of An Investigation Involving Possible Securities Fraud Violations By Certain Officers And Directors Of Cempra, Inc.
2016-11-02,IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces An Investigation Of Cempra, Inc. And Encourages Investors With Losses To Contact The Firm
2016-11-02,SHAREHOLDER ALERT: Brower Piven Commences An Investigation Into Cempra Inc. And Encourages Investors To Contact The Firm For Additional Information
2016-11-01,Cempra Receives $10 Million Milestone Payment From Toyama Chemical (a Subsidiary Of FUJIFILM Holdings Corporation) As Solithromycin Progresses To Phase 3 Studies In Japan
2016-10-31,Bullish and Bearish Reversals for the Week
2016-10-27,Cempra Reports Third Quarter 2016 Financial Results And Provides Corporate Update
2016-10-25,Cempra To Report Third Quarter 2016 Financial Results
2016-10-04,Cempra Presents Analysis Showing Rates Of Failure For Existing CABP Antibiotics From Claims Database At Academy Of Managed Care Pharmacy Meeting
2016-09-29,Cempra Announces Anti-NASH Effects Of Solithromycin: Interim Results From Phase 2 Study
2016-09-16,Cempra Is Ready to Run
2016-09-14,These 5 Biotech Stocks Are Ready for a Volatility Break
2016-09-01,Cempra To Present At Three Upcoming Investor Conferences
2016-08-30,Cempra To Present Solithromycin At FDA Antimicrobial Drugs Advisory Committee Meeting On November 4, 2016
2016-08-25,Cempra's Pivotal Phase 3 SOLITAIRE-IV Study Of IV To Oral Solithromycin Published In Clinical Infectious Diseases
2016-08-23,Cempra Announces European Medicines Agency Validates MAA For Solithromycin For Treatment Of CABP
2016-08-11,Cempra Appoints Dr. David Zaccardelli To Board Of Directors
2016-08-08,Perilous Reversal Watch: Cempra (CEMP)
2016-08-01,Cempra Reports Second Quarter 2016 Financial Results And Provides Corporate Update
2016-08-01,Cempra (CEMP) Is Today's Strong On High Volume Stock
2016-08-01,Cempra Appoints John Bluth Executive Vice President, Investor Relations And Corporate Communications
2016-07-25,Cempra To Report Second Quarter 2016 Financial Results
2016-07-14,Antibiotic for Treatment of Superbugs Could Send Cempra Shares Soaring
2016-07-12,Cempra (CEMP) Is Today's Strong On High Volume Stock
2016-07-05,Cempra Announces FDA Acceptance Of Solithera™ New Drug Applications In The Treatment Of Community-Acquired Bacterial Pneumonia
2016-06-28,Cempra Submits Marketing Authorization Application To EMA For Solithromycin In The Treatment Of Community-Acquired Bacterial Pneumonia
2016-06-21,Commit To Purchase Cempra At $15, Earn 36.5% Annualized Using Options
2016-06-16,Cempra To Host Analyst And Investor Day On June 23, 2016
2016-06-13,Strong On High Volume: Cempra (CEMP)
2016-06-10,Cempra Announces Solithromycin Presentations At ASM Microbe 2016 Conference
2016-06-06,Today's Dead Cat Bounce Stock: Cempra (CEMP)
2016-06-03,Cempra (CEMP) Stock: Weak On High Volume Today
2016-06-02,Cempra To Present At The Jefferies 2016 Healthcare Conference
2016-05-25,Cempra Announces Successful Results In The Phase 2 Community Acquired Bacterial Pneumonia (CABP) Trial Conducted By Japanese Partner, Toyama Chemical (a Subsidiary Of FUJIFILM Holdings Corporation)
2016-05-12,Cempra To Present Solithromycin IV Data At ATS 2016
2016-05-10,Cempra (CEMP): Today's Weak On High Volume Stock
2016-05-02,Cempra (CEMP) Strong On High Relative Volume Today
2016-05-01,Cempra Reports First Quarter 2016 Financial Results And Provides Corporate Update
2016-05-01,Cempra Completes NDA Submissions For Solithromycin In The Treatment Of Community-Acquired Bacterial Pneumonia
2016-04-25,Cempra To Report First Quarter 2016 Financial Results
2016-04-11,Facebook, Ford and General Motors: Doug Kass' Views
2016-04-06,Cempra To Present At The Needham And Company 15th Annual Healthcare Conference
2016-04-04,Cempra To Present Data On Solithromycin At ECCMID
2016-03-23,First Week of May 20th Options Trading For Cempra (CEMP)
2016-03-16,Insiders Now Seeing Red With CEMP At New 52-Week Low
2016-03-08,Cempra To Participate In Nature's Webcast On Combating Antibiotic Resistance On March 9
2016-03-07,Cempra Authorized To Receive Funds From BARDA For A Phase 2/3 Clinical Trial Of Solithromycin In Pediatric Patients
2016-03-07,Tesla, Amazon and Netflix: Doug Kass' Views
2016-03-01,CEMP: Insiders vs. Shorts
2016-03-01,Weak On High Volume: Cempra (CEMP)
2016-02-29,Cempra To Present At The Cowen And Company 36th Annual Healthcare Conference
2016-02-25,Interesting CEMP Put And Call Options For October 21st
2016-02-24,Cempra Reports Fourth Quarter And Full Year 2015 Financial Results And Provides Corporate Update
2016-02-19,What Carl Icahn Is Doing; Biotech Breakout: Best of Kass
2016-02-17,Cempra To Report Fourth Quarter And Full Year 2015 Financial Results
2016-02-15,JPMorgan, Deutsche Bank and Gilead Sciences: Doug Kass' Views
2016-02-05,The Lancet Infectious Diseases Publishes Positive Phase 3 Study Results For Cempra's Oral Solithromycin In Community-Acquired Bacterial Pneumonia
2016-02-03,Oversold Conditions For Cempra (CEMP)
2016-02-03,Cempra To Present At The Leerink Partners 5th Annual Global Healthcare Conference
2016-02-01,Cempra And Macrolide Pharmaceuticals Enter Synthetic Manufacturing Process Development Agreement For Solithromycin
2016-02-01,Biotech String: Assessing the January Damage, Gilead's Bottoming P/E, Sarepta Panel Date?
2016-01-29,Short Interest Moves 11.4% Lower For CEMP
2016-01-28,Spreading Zika Virus Is a Cause for Alarm, Says Cempra CEO
2016-01-28,Spreading Zika Virus Is a Cause for Alarm, Says Cempra CEO
2016-01-26,Cempra To Ring NASDAQ Closing Bell To Mark 10th Anniversary
2016-01-22,Interesting CEMP Put And Call Options For March 18th
2016-01-12,Cempra Completes Public Offering Of Common Stock
2016-01-07,Oversold Conditions For Cempra (CEMP)
2016-01-07,Heavy Trading On Cempra (CEMP) Before Market Open
2016-01-06,Cempra Prices Public Offering Of Common Stock
2016-01-06,Cempra To Present At J.P. Morgan Healthcare Conference
2016-01-05,Cempra Announces Proposed Public Offering Of $175 Million Of Common Stock
2016-01-05,Trade-Ideas: Cempra (CEMP) Is Today's "Dead Cat Bounce" Stock
2016-01-05,Cempra Doses Initial Patient In Phase 2 Clinical Trial Of Solithromycin In NASH
2015-12-29,2 Speculative Biotech Stocks for 2016
2015-12-22,Cempra Enters Into A CRADA With The NIAID And Expands The Phase 3 Solithromycin Clinical Trial In Urogenital Gonorrhea To Include Additional Female Patients And Adolescents
2015-12-09,Perilous Reversal Watch: Cempra (CEMP)
2015-12-08,Cempra Doses First Patient In Phase 3 Clinical Trial Of Taksta(TM) In Acute Bacterial Skin And Skin Structure Infections
2015-12-01,CEMP: Insiders vs. Shorts
2015-11-24,First Week of July 2016 Options Trading For Cempra (CEMP)
2015-11-24,Cempra (CEMP) Is Today's Perilous Reversal Stock
2015-11-11,Cempra To Present Anti-NASH Data For Solithromycin At The Liver Meeting(R) 2015
2015-11-10,Cempra To Present At Two Upcoming Investor Conferences
2015-11-02,Cempra (CEMP) Is Today's Dead Cat Bounce Stock
2015-10-30,Cempra’s New Drug Holds Potential, but Risk for Investors
2015-10-26,Cempra (CEMP) In A Perilous Reversal
2015-10-23,Cempra To Present Solithromycin Oral Data At CHEST 2015
2015-10-22,Cempra (CEMP): Today's Weak On High Volume Stock
2015-10-22,Cempra Reports Third Quarter 2015 Financial Results And Provides Corporate Update
2015-10-19,Cempra To Report Third Quarter 2015 Financial Results
2015-10-16,4 Big Stocks on Traders' Radars -- and What You Should Do With Them Now
2015-10-16,Heavy Trading On Cempra (CEMP) Before Market Open
2015-10-16,Cempra Announces Positive Topline Phase 3 Clinical Results For Intravenous Solithromycin In The Treatment Of Community-Acquired Bacterial Pneumonia
2015-10-14,Today's Dead Cat Bounce Stock: Cempra (CEMP)
2015-10-05,Cempra To Present Solithromycin Data At ID Week 2015
2015-09-24,Cempra To Present Solithromycin Data In COPD Patient Subgroup At European Respiratory Society International Congress
2015-09-22,Analysts Say Buy Select Biotech Stocks Ahead Of Clinton Drug Plan
2015-09-18,Strong On High Volume: Cempra (CEMP)
2015-09-18,FDA Grants Qualified Infectious Disease Product Designation To Taksta(TM) Cempra's Fusidic Acid Antibiotic
2015-09-16,CEMP Makes Notable Cross Below Critical Moving Average
2015-09-10,Cempra To Present Data From Antibiotic Drug Development Programs At ICAAC/ICC 2015 Meeting
2015-09-09,Trade-Ideas: Cempra (CEMP) Is Today's Weak On High Relative Volume Stock
2015-09-08,Cempra (CEMP) Flagged As Strong On High Volume
2015-09-03,Cempra To Present At Three Upcoming Investor Conferences
2015-08-20,Cempra (CEMP) In A Perilous Reversal
2015-08-19,FDA Grants Fast Track Designation To Cempra For Solithromycin In The Treatment Of Community Acquired Bacterial Pneumonia
2015-08-07,Today's Weak On High Volume Stock: Cempra (CEMP)
2015-08-04,Cempra To Present At The Wedbush PacGrow 2015 Healthcare Conference
2015-07-31,Cempra (CEMP) Is Today's Dead Cat Bounce Stock
2015-07-29,Cempra Reports Second Quarter 2015 Financial Results And Provides Corporate Update
2015-07-22,Cempra To Report Second Quarter 2015 Financial Results
2015-07-21,First Week Of CEMP September 18th Options Trading
2015-07-21,Stock To Watch: Cempra (CEMP) In Perilous Reversal
2015-07-17,New Lifetime High Reached: Cempra (CEMP)
2015-07-07,Cempra Completes Patient Enrollment Of Solitaire-IV Phase 3 Clinical Trial
2015-07-01,Cempra (CEMP) Is Today's Perilous Reversal Stock
2015-06-30,Cempra (CEMP) Showing Signs Of A Dead Cat Bounce Today
2015-06-24,Stock To Watch: Cempra (CEMP) In Perilous Reversal
2015-05-26,Cempra To Present At The Jefferies 2015 Global Healthcare Conference
2015-05-19,First Week Of January 2016 Options Trading For Cempra (CEMP)
2015-05-19,Cempra Presenting Additional Data From The Phase 3 Oral Solithromycin Study In Community Acquired Bacterial Pneumonia At The American Thoracic Society Conference
2015-05-12,Cempra To Present Solithromycin Data At Two Upcoming Medical Conferences
2015-05-01,Trade-Ideas: Cempra (CEMP) Is Today's Strong On High Relative Volume Stock
2017-03-13,Biotech Premarket Movers: Cempra, Blueprint Medicines, Aralez
2017-03-13,Cempra Retains Morgan Stanley To Lead Review Of Strategic Business Options
2017-03-03,Cempra To Present At 29th Annual ROTH Conference
2017-02-28,Biotech Premarket Movers: Cempra, Novavax, Ionis
2017-02-28,Cempra Provides Corporate Update And Reports Fourth Quarter And Full Year 2016 Financial Results
2017-02-27,Biotech Premarket Movers: BioCryst, Sangamo, Cempra
2017-02-24,4 Biotech Stocks on the Move
2017-02-24,Biotech Movers: Cempra Flys High On Phase Three Results
2017-02-24,Cempra's Fusidic Acid Achieves Primary Endpoint In Phase 3 Study Of ABSSSI
2017-02-14,Cempra To Report Fourth Quarter And Full Year 2016 Financial Results
2017-02-09,Acorda, Amgen and Regeneron Lead Premarket Biotech Movers
2017-02-08,CORRECTING And REPLACING -- Cempra To Present At Upcoming Investor Conferences
2017-02-08,Cempra To Present At Upcoming Investor Conferences
2017-01-04,Cempra To Present At J.P. Morgan Healthcare Conference
2017-01-03,INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders Of Cempra, Inc. Of A Class Action Lawsuit And A Lead Plaintiff Deadline Of January 3, 2017
2016-12-30,GPM Reminds Investors Of The January 3 Deadline In The Class Action Lawsuit Against Cempra, Inc.
2016-12-29,Wall Street Falls Again as Financial Stocks Lead the Decline
2016-12-29,Wall Street Slumps As Financial Stocks Lead the Decline
2016-12-29,Midday Report: Volatile Stocks Turn Negative; Cempra Plummets, Sears Soars
2016-12-29,Stocks Volatile After Trade Deficit Data; Oil Inventories Rise
2016-12-29,Cempra Receives Complete Response Letter From FDA For Solithromycin NDAs
2016-12-27,CEMP SHAREHOLDER ALERT: The Law Offices Of Vincent Wong Reminds Shareholders Of Commencement Of A Class Action Involving Cempra, Inc. And A Lead Plaintiff Deadline Of January 3, 2017
2016-12-23,CEMP INVESTOR ALERT: The Law Offices Of Vincent Wong Reminds Shareholders Of Commencement Of A Class Action Involving Cempra, Inc. And A Lead Plaintiff Deadline Of January 3, 2017
2016-12-20,Interesting CEMP Put And Call Options For February 2017
2016-12-16,CEMP SHAREHOLDER ALERT: The Law Offices Of Vincent Wong Reminds Shareholders Of A Class Action Involving Cempra, Inc. And A Lead Plaintiff Deadline Of January 3, 2017
2016-12-15,CEMP LOSS NOTICE: Rosen Law Firm Reminds Cempra, Inc. Investors Of Important Deadline In Class Action - CEMP
2016-12-14,CEMPRA INC. INVESTOR REMINDER: Hagens Berman Reminds Cempra Investors Of Lead Plaintiff Deadline
2016-12-12,Cempra Appoints Dr. David Zaccardelli As Acting Chief Executive Officer, Promotes Chief Commercial Officer David Moore To President
2016-12-07,DEADLINE ALERT: Brower Piven Alerts Shareholders Of Approaching Deadline In Class Action Lawsuit And Encourages Those With Losses In Excess Of $100,000 From Investment In Cempra, Inc. To Contact The Firm
2016-12-05,Toyama Chemical (a Subsidiary Of FUJIFILM Holdings Corporation) Begins Phase 3 Studies In Japan With Cempra's Solithromycin
2016-12-01,Lifshitz & Miller Law Firm Announces Investigation Of Adeptus Health Inc., Avid Technology, Inc., Cempra, Inc., Clovis Oncology, Inc., Impax Laboratories, Inc., Ligand Pharmaceuticals Incorporated, Pattern Energy Group Inc. And Kandi Technologies Group, Inc.
2016-11-30,Rosen Law Firm Reminds Cempra, Inc. Investors Of Important Deadline In Class Action - CEMP
2016-11-28,SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Cempra, Inc. To Contact The Firm Before Lead Plaintiff Deadline
2016-11-28,Short Interest Decreases By 21.6% For CEMP
2016-11-23,'Mad Money' Lightning Round: Jim Cramer Sees Steel Companies Shining
2016-11-22,Robbins Geller Rudman & Dowd LLP Files Class Action Suit Against Cempra, Inc.
2016-11-22,Jim Cramer's 'Mad Money' Recap: Expect More Earnings Surprises
2016-11-22,First Week of CEMP July 2017 Options Trading
2016-11-16,CEMPRA (CEMP) SHAREHOLDER ALERT: Johnson & Weaver, LLP Announces Filing Of Class Action Complaint Against Cempra, Inc.; Encourages All Investors To Contact The Firm For Information
2016-11-14,SHAREHOLDER ALERT: Securities Class Action Lawsuit Against Cempra Announced By Holzer & Holzer; Firm Investigating Expanded Class Period
2016-11-11,SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses On Their Investment In Cempra, Inc. Of Class Action Lawsuit And Upcoming Deadline - CEMP
2016-11-11,EQUITY ALERT: Rosen Law Firm Announces Filing Of Securities Class Action Lawsuit Against Cempra, Inc.
2016-11-09,Cempra To Present At Two Upcoming Investor Conferences
2016-11-08,IMPORTANT INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit Against Cempra, Inc. And Encourages Investors With Losses In Excess Of $250,000 To Contact The Firm
2016-11-08,SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors Of Class Action Against Cempra Inc. (CEMP) And Lead Plaintiff Deadline - January 3, 2017
2016-11-08,IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit Against Cempra, Inc. And Encourages Investors With Losses To Contact The Firm
2016-11-07,IMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit Against Cempra, Inc. And Encourages Investors With Losses In Excess Of $250,000 To Contact The Firm
2016-11-07,EQUITY ALERT: Rosen Law Firm Announces Filing Of Securities Class Action Lawsuit Against Cempra, Inc. - CEMP
2016-11-07,Cempra Antibiotic Approval Still in Doubt Even With Positive FDA Panel Vote
2016-11-04,FDA Advisory Committee Votes That Efficacy Results Of Cempra's Solithromycin Outweigh Risks For Community-Acquired Bacterial Pneumonia
2016-11-04,Cempra Stock Trading Halted Today; FDA Advisory Committee To Discuss Solithromycin
2016-11-03,Cempra (CEMP) Stock Downgraded at JPMorgan on FDA Pneumonia Drug Review
2016-11-03,SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf Of Investors Of Cempra, Inc. - CEMP
2016-11-03,IMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces An Investigation Of Cempra, Inc. And Advises Investors With Losses To Contact The Firm
2016-11-03,SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation Of Cempra Inc. (CEMP)
2016-11-03,'Mad Money' Lightning Round: J.C. Penney Is 'A Lot Better,' Jim Cramer Says
2016-11-02,Jim Cramer's 'Mad Money' Recap: It's Chicago Versus Cleveland -- Stocks, That Is
2016-11-02,INVESTOR ALERT: Goldberg Law PC Announces An Investigation Of Cempra, Inc. And Advises Investors With Losses In Excess Of $200,000 To Contact The Firm
2016-11-02,SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces The Commencement Of An Investigation Involving Possible Securities Fraud Violations By Certain Officers And Directors Of Cempra, Inc.
2016-11-02,IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces An Investigation Of Cempra, Inc. And Encourages Investors With Losses To Contact The Firm
2016-11-02,SHAREHOLDER ALERT: Brower Piven Commences An Investigation Into Cempra Inc. And Encourages Investors To Contact The Firm For Additional Information
2016-11-01,Cempra Receives $10 Million Milestone Payment From Toyama Chemical (a Subsidiary Of FUJIFILM Holdings Corporation) As Solithromycin Progresses To Phase 3 Studies In Japan
2016-10-31,Bullish and Bearish Reversals for the Week
2016-10-27,Cempra Reports Third Quarter 2016 Financial Results And Provides Corporate Update
2016-10-25,Cempra To Report Third Quarter 2016 Financial Results
2016-10-04,Cempra Presents Analysis Showing Rates Of Failure For Existing CABP Antibiotics From Claims Database At Academy Of Managed Care Pharmacy Meeting
2016-09-29,Cempra Announces Anti-NASH Effects Of Solithromycin: Interim Results From Phase 2 Study
2016-09-16,Cempra Is Ready to Run
2016-09-14,These 5 Biotech Stocks Are Ready for a Volatility Break
2016-09-01,Cempra To Present At Three Upcoming Investor Conferences
2016-08-30,Cempra To Present Solithromycin At FDA Antimicrobial Drugs Advisory Committee Meeting On November 4, 2016
2016-08-25,Cempra's Pivotal Phase 3 SOLITAIRE-IV Study Of IV To Oral Solithromycin Published In Clinical Infectious Diseases
2016-08-23,Cempra Announces European Medicines Agency Validates MAA For Solithromycin For Treatment Of CABP
2016-08-11,Cempra Appoints Dr. David Zaccardelli To Board Of Directors
2016-08-08,Perilous Reversal Watch: Cempra (CEMP)
2016-08-01,Cempra Reports Second Quarter 2016 Financial Results And Provides Corporate Update
2016-08-01,Cempra (CEMP) Is Today's Strong On High Volume Stock
2016-08-01,Cempra Appoints John Bluth Executive Vice President, Investor Relations And Corporate Communications
2016-07-25,Cempra To Report Second Quarter 2016 Financial Results
2016-07-14,Antibiotic for Treatment of Superbugs Could Send Cempra Shares Soaring
2016-07-12,Cempra (CEMP) Is Today's Strong On High Volume Stock
2016-07-05,Cempra Announces FDA Acceptance Of Solithera™ New Drug Applications In The Treatment Of Community-Acquired Bacterial Pneumonia
2016-06-28,Cempra Submits Marketing Authorization Application To EMA For Solithromycin In The Treatment Of Community-Acquired Bacterial Pneumonia
2016-06-21,Commit To Purchase Cempra At $15, Earn 36.5% Annualized Using Options
2016-06-16,Cempra To Host Analyst And Investor Day On June 23, 2016
2016-06-13,Strong On High Volume: Cempra (CEMP)
2016-06-10,Cempra Announces Solithromycin Presentations At ASM Microbe 2016 Conference
2016-06-06,Today's Dead Cat Bounce Stock: Cempra (CEMP)
2016-06-03,Cempra (CEMP) Stock: Weak On High Volume Today
2016-06-02,Cempra To Present At The Jefferies 2016 Healthcare Conference
2016-05-25,Cempra Announces Successful Results In The Phase 2 Community Acquired Bacterial Pneumonia (CABP) Trial Conducted By Japanese Partner, Toyama Chemical (a Subsidiary Of FUJIFILM Holdings Corporation)
2016-05-12,Cempra To Present Solithromycin IV Data At ATS 2016
2016-05-10,Cempra (CEMP): Today's Weak On High Volume Stock
2016-05-02,Cempra (CEMP) Strong On High Relative Volume Today
2016-05-01,Cempra Reports First Quarter 2016 Financial Results And Provides Corporate Update
2016-05-01,Cempra Completes NDA Submissions For Solithromycin In The Treatment Of Community-Acquired Bacterial Pneumonia
2016-04-25,Cempra To Report First Quarter 2016 Financial Results
2016-04-11,Facebook, Ford and General Motors: Doug Kass' Views
2016-04-06,Cempra To Present At The Needham And Company 15th Annual Healthcare Conference
2016-04-04,Cempra To Present Data On Solithromycin At ECCMID
2016-03-23,First Week of May 20th Options Trading For Cempra (CEMP)
2016-03-16,Insiders Now Seeing Red With CEMP At New 52-Week Low
2016-03-08,Cempra To Participate In Nature's Webcast On Combating Antibiotic Resistance On March 9
2016-03-07,Cempra Authorized To Receive Funds From BARDA For A Phase 2/3 Clinical Trial Of Solithromycin In Pediatric Patients
2016-03-07,Tesla, Amazon and Netflix: Doug Kass' Views
2016-03-01,CEMP: Insiders vs. Shorts
2016-03-01,Weak On High Volume: Cempra (CEMP)
2016-02-29,Cempra To Present At The Cowen And Company 36th Annual Healthcare Conference
2016-02-25,Interesting CEMP Put And Call Options For October 21st
2016-02-24,Cempra Reports Fourth Quarter And Full Year 2015 Financial Results And Provides Corporate Update
2016-02-19,What Carl Icahn Is Doing; Biotech Breakout: Best of Kass
2016-02-17,Cempra To Report Fourth Quarter And Full Year 2015 Financial Results
2016-02-15,JPMorgan, Deutsche Bank and Gilead Sciences: Doug Kass' Views
2016-02-05,The Lancet Infectious Diseases Publishes Positive Phase 3 Study Results For Cempra's Oral Solithromycin In Community-Acquired Bacterial Pneumonia
2016-02-03,Oversold Conditions For Cempra (CEMP)
2016-02-03,Cempra To Present At The Leerink Partners 5th Annual Global Healthcare Conference
2016-02-01,Cempra And Macrolide Pharmaceuticals Enter Synthetic Manufacturing Process Development Agreement For Solithromycin
2016-02-01,Biotech String: Assessing the January Damage, Gilead's Bottoming P/E, Sarepta Panel Date?
2016-01-29,Short Interest Moves 11.4% Lower For CEMP
2016-01-28,Spreading Zika Virus Is a Cause for Alarm, Says Cempra CEO
2016-01-28,Spreading Zika Virus Is a Cause for Alarm, Says Cempra CEO
2016-01-26,Cempra To Ring NASDAQ Closing Bell To Mark 10th Anniversary
2016-01-22,Interesting CEMP Put And Call Options For March 18th
2016-01-12,Cempra Completes Public Offering Of Common Stock
2016-01-07,Oversold Conditions For Cempra (CEMP)
2016-01-07,Heavy Trading On Cempra (CEMP) Before Market Open
2016-01-06,Cempra Prices Public Offering Of Common Stock
2016-01-06,Cempra To Present At J.P. Morgan Healthcare Conference
2016-01-05,Cempra Announces Proposed Public Offering Of $175 Million Of Common Stock
2016-01-05,Trade-Ideas: Cempra (CEMP) Is Today's "Dead Cat Bounce" Stock
2016-01-05,Cempra Doses Initial Patient In Phase 2 Clinical Trial Of Solithromycin In NASH
2015-12-29,2 Speculative Biotech Stocks for 2016
2015-12-22,Cempra Enters Into A CRADA With The NIAID And Expands The Phase 3 Solithromycin Clinical Trial In Urogenital Gonorrhea To Include Additional Female Patients And Adolescents
2015-12-09,Perilous Reversal Watch: Cempra (CEMP)
2015-12-08,Cempra Doses First Patient In Phase 3 Clinical Trial Of Taksta(TM) In Acute Bacterial Skin And Skin Structure Infections
2015-12-01,CEMP: Insiders vs. Shorts
2015-11-24,First Week of July 2016 Options Trading For Cempra (CEMP)
2015-11-24,Cempra (CEMP) Is Today's Perilous Reversal Stock
2015-11-11,Cempra To Present Anti-NASH Data For Solithromycin At The Liver Meeting(R) 2015
2015-11-10,Cempra To Present At Two Upcoming Investor Conferences
2015-11-02,Cempra (CEMP) Is Today's Dead Cat Bounce Stock
2015-10-30,Cempra’s New Drug Holds Potential, but Risk for Investors
2015-10-26,Cempra (CEMP) In A Perilous Reversal
2015-10-23,Cempra To Present Solithromycin Oral Data At CHEST 2015
2015-10-22,Cempra (CEMP): Today's Weak On High Volume Stock
2015-10-22,Cempra Reports Third Quarter 2015 Financial Results And Provides Corporate Update
2015-10-19,Cempra To Report Third Quarter 2015 Financial Results
2015-10-16,4 Big Stocks on Traders' Radars -- and What You Should Do With Them Now
2015-10-16,Heavy Trading On Cempra (CEMP) Before Market Open
2015-10-16,Cempra Announces Positive Topline Phase 3 Clinical Results For Intravenous Solithromycin In The Treatment Of Community-Acquired Bacterial Pneumonia
2015-10-14,Today's Dead Cat Bounce Stock: Cempra (CEMP)
2015-10-05,Cempra To Present Solithromycin Data At ID Week 2015
2015-09-24,Cempra To Present Solithromycin Data In COPD Patient Subgroup At European Respiratory Society International Congress
2015-09-22,Analysts Say Buy Select Biotech Stocks Ahead Of Clinton Drug Plan
2015-09-18,Strong On High Volume: Cempra (CEMP)
2015-09-18,FDA Grants Qualified Infectious Disease Product Designation To Taksta(TM) Cempra's Fusidic Acid Antibiotic
2015-09-16,CEMP Makes Notable Cross Below Critical Moving Average
2015-09-10,Cempra To Present Data From Antibiotic Drug Development Programs At ICAAC/ICC 2015 Meeting
2015-09-09,Trade-Ideas: Cempra (CEMP) Is Today's Weak On High Relative Volume Stock
2015-09-08,Cempra (CEMP) Flagged As Strong On High Volume
2015-09-03,Cempra To Present At Three Upcoming Investor Conferences
2015-08-20,Cempra (CEMP) In A Perilous Reversal
2015-08-19,FDA Grants Fast Track Designation To Cempra For Solithromycin In The Treatment Of Community Acquired Bacterial Pneumonia
2015-08-07,Today's Weak On High Volume Stock: Cempra (CEMP)
2015-08-04,Cempra To Present At The Wedbush PacGrow 2015 Healthcare Conference
2015-07-31,Cempra (CEMP) Is Today's Dead Cat Bounce Stock
2015-07-29,Cempra Reports Second Quarter 2015 Financial Results And Provides Corporate Update
2015-07-22,Cempra To Report Second Quarter 2015 Financial Results
2015-07-21,First Week Of CEMP September 18th Options Trading
2015-07-21,Stock To Watch: Cempra (CEMP) In Perilous Reversal
2015-07-17,New Lifetime High Reached: Cempra (CEMP)
2015-07-07,Cempra Completes Patient Enrollment Of Solitaire-IV Phase 3 Clinical Trial
2015-07-01,Cempra (CEMP) Is Today's Perilous Reversal Stock
2015-06-30,Cempra (CEMP) Showing Signs Of A Dead Cat Bounce Today
2015-06-24,Stock To Watch: Cempra (CEMP) In Perilous Reversal
2015-05-26,Cempra To Present At The Jefferies 2015 Global Healthcare Conference
2015-05-19,First Week Of January 2016 Options Trading For Cempra (CEMP)
2015-05-19,Cempra Presenting Additional Data From The Phase 3 Oral Solithromycin Study In Community Acquired Bacterial Pneumonia At The American Thoracic Society Conference
2015-05-12,Cempra To Present Solithromycin Data At Two Upcoming Medical Conferences
2015-05-01,Trade-Ideas: Cempra (CEMP) Is Today's Strong On High Relative Volume Stock
